NOV-002
Saturday, December 12, 2009 - 12:07
in Health & Medicine
NOV-002, a proprietary formulation of oxidized glutathione, is the lead compound of Novelos Therapeutics Inc (NVLT). NOV-002 acts as a chemopotentiator and a chemoprotectant, in combination with chemotherapy, by regulating redox-sensitive cell signaling pathways.